<?xml version="1.0" encoding="UTF-8"?>
<results title="migration">
 <result pre="model. Taken together, these results verified that AAM effectively inhibits" exact="migration" post="and VM formation by suppressing ROS/HIF-1α/MMP2 pathway in colorectal"/>
 <result pre="formation in human colorectal cancer. Astragalus Atractylodes mixture colorectal cancer" exact="migration" post="vasculogenic mimicry hypoxia Funding National Natural Science Foundation of"/>
 <result pre="page-count: word-count: Highlights High level of ROS is associated with" exact="migration" post="in colorectal cancer cells. In highly metastatic colorectal cancer"/>
 <result pre="requires ROS generation in colorectal cancer cells. AAM effectively inhibits" exact="migration" post="and VM formation by suppressing ROS/HIF-1α/MMP2 axis under hypoxic"/>
 <result pre="showed that AAM suppresses CRC vasculogenic mimicry (VM) formation and" exact="migration" post="through inhibiting the ROS/HIF-1α pathway in a hypoxic microenvironment."/>
 <result pre="NAC (10 mM) for 24 h. To measure the cells’" exact="migration" post="ability, the same area of the well was observed"/>
 <result pre="measured by Image J. Transwell Migration Assay Additionally, the cell" exact="migration" post="was measured with Transwell system (#3422, Corning). Firstly, 5"/>
 <result pre="Migration Under Hypoxia Condition To investigate whether ROS affects the" exact="migration" post="of colorectal cancer, HCT-116 cells were treated with different"/>
 <result pre="NAC and then exposed in normoxia and hypoxia conditions. The" exact="migration" post="ability of HCT-116 cells was evaluated using wound-healing assay."/>
 <result pre="using wound-healing assay. As shown in the Figure 2, the" exact="migration" post="distance of HCT-116 cells is dose dependent on hypoxia"/>
 <result pre="HCT-116 cells is dose dependent on hypoxia condition; however, the" exact="migration" post="ability is not affected by the low dose (1.25,"/>
 <result pre="condition. These results suggest that the ROS level regulated the" exact="migration" post="ability of colorectal cancer cells under hypoxia condition. Figure"/>
 <result pre="under hypoxia condition. Figure 2 NAC inhibits colorectal cancer cell" exact="migration" post="under hypoxia condition. Wound-healing assay for evaluating the migration"/>
 <result pre="cell migration under hypoxia condition. Wound-healing assay for evaluating the" exact="migration" post="ability of HCT-116 cells under normoxia (A) and hypoxia"/>
 <result pre="ROS Generation In view of the fact that tumor cell" exact="migration" post="is not only critical to cancer metastasis, but also"/>
 <result pre="2011; Cao et al., 2013), we explored whether hypoxia accelerates" exact="migration" post="in colorectal cancer. HCT-116 and LoVo cells were exposed"/>
 <result pre="hypoxic condition (1% O2) for 24 h, and then their" exact="migration" post="ability was analyzed using Transwell migration assay and wound-healing"/>
 <result pre="h, and then their migration ability was analyzed using Transwell" exact="migration" post="assay and wound-healing assay. As shown in Figure S1,"/>
 <result pre="wound-healing assay. As shown in Figure S1, hypoxia could accelerate" exact="migration" post="of both HCT-116 and LoVo cells compared to the"/>
 <result pre="mM NAC). In line with the results obtained by Transwell" exact="migration" post="assay, the wound-healing assay also showed that colorectal cancer"/>
 <result pre="ROS generation in colorectal cancer cells. Figure 4 Hypoxia accelerates" exact="migration" post="and requires ROS generation. Transwell assay was used to"/>
 <result pre="used to evaluate the effect of hypoxia and ROS on" exact="migration" post="ability. LoVo (A) and HCT-116 (B) cells were cultured"/>
 <result pre="Under Hypoxia We investigated the effect of AAM on hypoxia-induced" exact="migration" post="and VM formation. The wound-healing assay showed that AAM"/>
 <result pre="wound-healing assay showed that AAM could significantly suppress the hypoxia-induced" exact="migration" post="of colorectal cancer HCT-116 and LoVo cells (Figures 8A,"/>
 <result pre="cancer HCT-116 and LoVo cells (Figures 8A, B). The Transwell" exact="migration" post="assay indicated that the hypoxia-induced migration of HCT-116 and"/>
 <result pre="8A, B). The Transwell migration assay indicated that the hypoxia-induced" exact="migration" post="of HCT-116 and LoVo cells was also inhibited by"/>
 <result pre="Together, these results validate that AAM could inhibit the hypoxia-induced" exact="migration" post="and VM formation. Figure 8 AAM inhibits migration of"/>
 <result pre="the hypoxia-induced migration and VM formation. Figure 8 AAM inhibits" exact="migration" post="of HCT-116 and LoVo cells. (A, B) Wound-healing assays"/>
 <result pre="2018). Our study also found that hypoxia could promote the" exact="migration" post="and VM formation in CRC. However, the mechanism of"/>
 <result pre="2018). Therefore, a drug that effectively inhibits the tumor cell" exact="migration" post="would be a potential agent to suppress VM formation."/>
 <result pre="this context, the results showed that AAM significantly suppressed hypoxia-induced" exact="migration" post="of HCT-116 and LoVo cells. Previous studies have demonstrated"/>
 <result pre="Conclusions Taken together, these results verified that AAM effectively inhibits" exact="migration" post="and VM formation by suppressing the ROS/HIF-1α/MMP2 pathway in"/>
 <result pre="or financial relationships that could be construed as a potential" exact="conflict" post="of interest. Supplementary Material The Supplementary Material for this"/>
 <result pre="Click here for additional data file. Figure S2 Hypoxia accelerates" exact="migration" post="and requires ROS generation. Wound-healing assays of HCT-116 and"/>
</results>
